Cite

HARVARD Citation

    Moore, A. et al. (n.d.). P44 Stable pharmacokinetics and biochemical markers of IBD activity: results from real-world adalimumab biosimilar switching program. Gut. pp. A59-A60. [Online]. 
  
Back to record